2465 — Leadtek Research Income Statement
0.000.00%
Last trade - 00:00
- TWD10.28bn
- TWD10.35bn
- TWD4.28bn
- 42
- 10
- 64
- 28
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,640 | 4,548 | 8,823 | 5,311 | 4,276 |
Cost of Revenue | |||||
Gross Profit | 487 | 563 | 1,570 | 607 | 628 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,626 | 4,495 | 8,269 | 5,464 | 4,375 |
Operating Profit | 13.8 | 53.1 | 554 | -152 | -98.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.39 | 54.7 | 546 | -201 | -133 |
Provision for Income Taxes | |||||
Net Income After Taxes | -24.6 | 24.8 | 435 | -196 | -160 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -19.3 | 26.8 | 435 | -196 | -160 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -19.3 | 26.8 | 435 | -196 | -160 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.33 | 0.437 | 7.37 | -3.31 | -2.53 |
Dividends per Share |